Identifiants & Marche
Ticker
BVXV
ISIN
US09073Q1058
CIK
0001611747
Bourse
NASDAQ
Devise
USD
Entreprise
Pays
IL
Siege
N/A
Fondee
N/A
Description
BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.